Skip to content
value.today
Conventus Orthopaedics Inc. logo

Conventus Orthopaedics Inc.

Total raised
$104 M
7 rounds on record
Latest round
$24 M
Apr 2020
First round on record
Jun 2009
Today
Private
No later event on record

Funding rounds

7 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Conventus Orthopaedics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2020$40 MIssued in a merger or acquisition$10 to $50 million

Conventus Orthopaedics Inc.: Private sale, May 2020

Investors in this round

33 investors had bought by the notice of May 18, 2020: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$40 M of $42 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jonathan Isenburg · Executive Officer
  • Richard Epstein · Executive Officer, Director
  • Andrew ElBardissi · Director
  • George Jenkins · Director
  • Richard Mott · Director
  • Scott Flora · Director
  • Shaden Marzouk · Director
  • Steven Hochberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Epstein, Chief Executive Officer. Source: SEC Form D, newest notice filed May 18, 2020. Read the notice at the SEC.

equitySEC
Apr 2020$24 MNo. 7$10 to $50 million

Conventus Orthopaedics Inc.: Raise no. 7, Apr 2020

Investors in this round

1 investor had bought by the notice of May 14, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $24 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jonathan Isenburg · Executive Officer
  • Richard Epstein · Executive Officer, Director
  • Andrew ElBardissi · Director
  • George Jenkins · Director
  • Richard Mott · Director
  • Scott Flora · Director
  • Shaden Marzouk · Director
  • Steven Hochberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Epstein, Chief Executive Officer. Source: SEC Form D, newest notice filed May 14, 2020. Read the notice at the SEC.

equitySEC
Dec 2018$5 MNo. 6$2 to $10 million

Conventus Orthopaedics Inc.: Raise no. 6, Dec 2018

Investors in this round

1 investor had bought by the notice of Jan 10, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, other: Subordinated Convertible Promissory Notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Matt Jewett · Executive Officer, Director
  • Shaden Marzouk · Executive Officer
  • Andrew ElBardissi · Director
  • Charles Chon · Director
  • Joseph Biller · Director
  • Richard Mott · Director
  • Scott Flora · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Matthew Jewett, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 10, 2019. Read the notice at the SEC.

debt, optionsSEC
Apr 2017$20 MNo. 5$10 to $50 million

Conventus Orthopaedics Inc.: Raise no. 5, Apr 2017

Investors in this round

6 investors had bought by the notice of Dec 27, 2017: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kent Lind · Executive Officer
  • Matt Jewett · Executive Officer, Director
  • Andrew Daniel ElBardissi · Director
  • Charles Daniel Chon · Director
  • Joseph Biller · Director
  • Richard Daniel Mott · Director
  • Scott Daniel Flora · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Matt Jewett, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Dec 27, 2017. Read the notice at the SEC.

equitySEC
Oct 2015$23 MNo. 4$10 to $50 million

Conventus Orthopaedics Inc.: Raise no. 4, Oct 2015

Investors in this round

9 investors had bought by the notice of Nov 12, 2015: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
$153,125
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$3,450,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Blue · Executive Officer
  • John Feriancek · Executive Officer
  • Kent Lind · Executive Officer
  • Michael Brenzel · Executive Officer
  • Paul Buckman · Executive Officer
  • Paul Hindrichs · Executive Officer
  • Avi Daniel Kometz, M.D. · Director
  • Charles Daniel Chon · Director
  • J. Daniel Cole · Director
  • Joseph Daniel Biller · Director
  • Rod Daniel Mayer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Buckman, President & CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 12, 2015. Read the notice at the SEC.

equitySEC
Sep 2013$18 MNo. 3$10 to $50 million

Conventus Orthopaedics Inc.: Raise no. 3, Sep 2013

Investors in this round

15 investors had bought by the notice of Dec 17, 2013: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $25 M offered; $7 M still to sell
Smallest investment taken
$46
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$928,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Blue · Executive Officer
  • Kent Lind · Executive Officer
  • Leota Pearson · Executive Officer
  • Michael Brenzel · Executive Officer
  • Paul Buckman · Executive Officer, Director
  • Paul Hindrichs · Executive Officer
  • J. Daniel Cole · Director
  • Joseph Daniel Biller · Director
  • Rod Daniel Mayer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Buckman, President & CEO. Source: SEC Form D and 1 amendment, newest notice filed Dec 17, 2013. Read the notice at the SEC.

equitySEC
Aug 2012$5 MNo. 2$2 to $10 million

Conventus Orthopaedics Inc.: Raise no. 2, Aug 2012

Investors in this round

2 investors had bought by the notice of Mar 4, 2013: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $9 M offered; $3 M still to sell
Smallest investment taken
$112,500
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kent Daniel Lind · Executive Officer
  • Leota Daniel Pearson · Executive Officer
  • Michael Brenzel · Executive Officer
  • Paul Hindrichs · Executive Officer, Director
  • Robert A. Kukuljan · Executive Officer
  • Thurman Daniel Ballard · Executive Officer
  • J. Daniel Cole · Director
  • Kenneth Daniel LIn · Director
  • Paul Daniel Buckman · Director
  • Rod Daniel Mayer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Hindrichs, Chief Executive Officer and President. Source: SEC Form D and 1 amendment, newest notice filed Mar 4, 2013. Read the notice at the SEC.

debt, optionsSEC
Jun 2009$7 MNo. 1$2 to $10 million

Conventus Orthopaedics Inc.: Raise no. 1, Jun 2009

Investors in this round

2 investors had bought by the notice of Jun 19, 2009: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $0 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$390,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael P Brenzel · Executive Officer
  • Paul Hindrichs · Executive Officer, Director
  • Robert A Kukuljan · Executive Officer
  • D. Keith Grossman · Director
  • J. Daniel Cole · Director
  • Paul Buckman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Hindrichs, CEO and President. Source: SEC Form D, newest notice filed Jun 19, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Conventus Orthopaedics Inc. chose not to state its revenue in its newest notice of a funding round (May 2020).

    SEC Form D · May 2020

  • Revenue range over time, as stated in its notices: no revenue in 2009; revenue of up to $1 million in 2013; revenue of up to $1 million in 2015.

    SEC Form D (revenue range) · Nov 2015

  • The industry group it chose in its notices: Manufacturing.

    SEC Form D · May 2020

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of Conventus Orthopaedics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Conventus Orthopaedics Inc.
NameRoleNamed in
Jonathan IsenburgExecutive officerMay 2020
Richard EpsteinExecutive officerMay 2020
Matt JewettExecutive officerJan 2019
Shaden MarzoukExecutive officerJan 2019
Kent LindExecutive officerDec 2017
John FeriancekExecutive officerMay 2017
Michael BrenzelExecutive officerMay 2017
David BlueExecutive officerNov 2015
Paul BuckmanExecutive officerNov 2015
Paul HindrichsExecutive officerNov 2015
Leota PearsonExecutive officerDec 2013
Kent Daniel LindExecutive officerMar 2013
Leota Daniel PearsonExecutive officerMar 2013
Robert A. KukuljanExecutive officerMar 2013
Thurman Daniel BallardExecutive officerMar 2013
Michael P BrenzelExecutive officerJun 2009
Robert A KukuljanExecutive officerJun 2009
Andrew ElBardissiDirectorMay 2020
George JenkinsDirectorMay 2020
Richard EpsteinDirectorMay 2020
Richard MottDirectorMay 2020
Scott FloraDirectorMay 2020
Shaden MarzoukDirectorMay 2020
Steven HochbergDirectorMay 2020
Charles ChonDirectorJan 2019
Joseph BillerDirectorJan 2019
Matt JewettDirectorJan 2019
Andrew Daniel ElBardissiDirectorDec 2017
Charles Daniel ChonDirectorDec 2017
Richard Daniel MottDirectorDec 2017
Scott Daniel FloraDirectorDec 2017
Avi Daniel Kometz, M.D.DirectorMay 2017
J. Daniel ColeDirectorMay 2017
Joseph Daniel BillerDirectorMay 2017
Rod Daniel MayerDirectorNov 2015
Paul BuckmanDirectorDec 2013
Kenneth Daniel LInDirectorMar 2013
Paul Daniel BuckmanDirectorMar 2013
Paul HindrichsDirectorMar 2013
Kenneith Daniel LInDirectorAug 2012

About

Company in Maple Grove, United States.